Page last updated: 2024-09-04

olmesartan and Cirrhosis, Liver

olmesartan has been researched along with Cirrhosis, Liver in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Ge, X; Wang, SN; Wu, Y; Zhang, CQ	1
Ioshii, SO; Précoma, DB; Sturzeneker, MC; Villela Baroncini, LA	1
Hidaka, H; Koizumi, W; Minamino, T; Nakazawa, T; Okuwaki, Y; Shibuya, A; Takada, J; Tanaka, Y; Watanabe, M	1
Aksak, S; Albayrak, A; Albayrak, F; Gundogdu, C; Halici, Z; Karakus, E; Kiki, I; Ozturk, B; Polat, B; Sipal, S	1
Akisawa, N; Hirose, A; Iwasaki, S; Masuda, K; Nozaki, Y; Oben, JA; Onishi, S; Ono, M; Saibara, T; Takahashi, M; Yoshioka, A	1

Trials

1 trial(s) available for olmesartan and Cirrhosis, Liver

Article	Year
Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial. Journal of gastroenterology, 2011, Volume: 46, Issue:11 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Collagen Type IV; Esophageal and Gastric Varices; Female; Humans; Hyaluronic Acid; Imidazoles; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Portal Pressure; Procollagen; Prospective Studies; Tetrazoles; Transforming Growth Factor beta1	2011

Article

Year

Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial.

Journal of gastroenterology, 2011, Volume: 46, Issue:11

Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Collagen Type IV; Esophageal and Gastric Varices; Female; Humans; Hyaluronic Acid; Imidazoles; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments; Portal Pressure; Procollagen; Prospective Studies; Tetrazoles; Transforming Growth Factor beta1

2011

Other Studies

4 other study(ies) available for olmesartan and Cirrhosis, Liver

Article	Year
Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis. BioMed research international, 2022, Volume: 2022 Topics: Angiotensin II; Animals; Carbon Tetrachloride; Collagen; Imidazoles; Interleukin-10; Liver Cirrhosis; Mice; Neovascularization, Pathologic; Tetrazoles; Vascular Endothelial Growth Factor A	2022
Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia. Atherosclerosis, 2011, Volume: 216, Issue:1 Topics: Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Blood Glucose; Cholesterol, Dietary; Disease Models, Animal; Fatty Liver; Hepatitis; Hypercholesterolemia; Imidazoles; Lipids; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Rabbits; Tetrazoles; Time Factors	2011
Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy. Journal of molecular histology, 2012, Volume: 43, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Diabetes Mellitus, Experimental; Imidazoles; Liver Cirrhosis; Losartan; Male; Microscopy, Electron; Rats; Tetrazoles; Valine; Valsartan	2012
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Animal Feed; Animals; Choline; Connective Tissue Growth Factor; Fatty Liver; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Liver Cirrhosis; Male; Methionine; Oxidative Stress; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2007